Results 251 to 260 of about 207,511 (311)

Immunotherapy‐Related Cutaneous Toxicities in Melanoma: A Dermoscopic Perspective

open access: yesJEADV Clinical Practice, EarlyView.
Dermoscopy serves as a valuable tool in the everyday dermatological and oncological practice for melanoma patients, allowing for the prompt identification of immune‐related cutaneous toxicities and guiding clinicians toward appropriate therapeutic decisions.
Grażyna Kamińska‐Winciorek   +3 more
wiley   +1 more source

Online multidisciplinary discussion on interstitial lung disease: Using new technologies to connect general hospitals to expert units. [PDF]

open access: yesSarcoidosis Vasc Diffuse Lung Dis
Francesqui J   +8 more
europepmc   +1 more source

Is Immunotherapy a Contraindication for Treating Lung Cancer Patients with Interstitial Lung Diseases? A Review of the Literature. [PDF]

open access: yesJ Clin Med
Pagliaro R   +11 more
europepmc   +1 more source

Pulmonary Veno-Occlusive Disease in Rheumatoid Arthritis: A Rare Pathological Entity Independent of Interstitial Lung Disease. [PDF]

open access: yesDiagnostics (Basel)
Izumi R   +10 more
europepmc   +1 more source

Interstitial lung diseases

The Lancet, 2022
Over 200 interstitial lung diseases, from ultra rare to relatively common, are recognised. Most interstitial lung diseases are characterised by inflammation or fibrosis within the interstitial space, the primary consequence of which is impaired gas exchange, resulting in breathlessness, diminished exercise tolerance, and decreased quality of life ...
Marlies, Wijsenbeek   +2 more
openaire   +2 more sources

Childhood Interstitial Lung Disease

Pediatric Allergy, Immunology, and Pulmonology, 2023
Childhood interstitial lung disease (chILD) is a heterogeneous group of diseases with various clinical and imaging findings. The incidence and prevalence have increased in recent years, probably due to better comprehension of these rare diseases and increased awareness among physicians.
Halime, Nayir Buyuksahin, Nural, Kiper
openaire   +2 more sources

Home - About - Disclaimer - Privacy